ARKIN BIO VENTURES
Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech and medical device technologies.
ARKIN BIO VENTURES
Industry:
Biotechnology
Founded:
2016-01-01
Status:
Active
Contact:
972-9-7883330
Similar Organizations
Aidmics
Aidmics Biotechnology is driven to make breakthroughs in the biotechnology field.
Biocrucible
Biocrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation.
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-05-09 | Bluejay Therapeutics | Arkin Bio Ventures investment in Series C - Bluejay Therapeutics | 182 M USD |
| 2024-05-02 | Reunion Neuroscience | Arkin Bio Ventures investment in Series A - Reunion Neuroscience | 103 M USD |
| 2022-12-06 | Entact Bio | Arkin Bio Ventures investment in Series A - Entact Bio | 81 M USD |
| 2022-09-08 | Photys Therapeutics | Arkin Bio Ventures investment in Series A - Photys Therapeutics | 75 M USD |
| 2022-08-16 | Bluejay Therapeutics | Arkin Bio Ventures investment in Series B - Bluejay Therapeutics | 41 M USD |
| 2022-07-20 | Auron Therapeutics | Arkin Bio Ventures investment in Series A - Auron Therapeutics | 48 M USD |
| 2021-01-28 | Auron Therapeutics | Arkin Bio Ventures investment in Seed Round - Auron Therapeutics | 12.75 M USD |
| 2021-01-07 | Werewolf Therapeutics | Arkin Bio Ventures investment in Series B - Werewolf Therapeutics | 72 M USD |
| 2020-12-02 | BioSight | Arkin Bio Ventures investment in Series C - BioSight | 27 M USD |
| 2020-03-25 | Redpin Therapeutics | Arkin Bio Ventures investment in Series A - Redpin Therapeutics | 15.5 M USD |
More informations about "Arkin Bio Ventures"
Arkin Bio | Arkin
Arkin Bio Multi-Stage Partners in Biotech Innovation. A leading global life sciences VC with funds focused on early-stage biotech through Arkin Bio Ventures and late-stage biotech via Arkin Bio Capital. With strong scientific …See details»
Arkin Bio Ventures - Crunchbase Investor Profile & Investments
Sub-Organization of . Arkin Holdings . Founded Date 2016; Founders Mori Arkin; Operating Status Active; Legal Name Arkin Bio Ventures L.P. Investor Type Venture Capital Investment …See details»
About | Arkin - Arkin Holdings
Arkin Bio Ventures 2 (Early Stage) Hedge Fund IDEA Hedge Fund. 2021. Capital Fund . Arkin Bio Capital (Late Stage) activity . Arkin Digital Health. 2023. activity . Arkin Sustainability. 2025. …See details»
Homepage | Arkin
Arkin leverages four main Investment arms to drive growth and deliver impactful investments through Arkin Health, Arkin Equity, Arkin Tech, and Arkin Real Estate. A leader in health …See details»
Arkin Bio - Israeli VC and Private Equity | Startup Nation Finder
Jun 16, 2016 Arkin Bio Ventures is a joint venture between insurance and finance company Phoenix Group (49%) and Arkin Holdings (51%). In 2016, the two companies announced a …See details»
Arkin Bio Ventures - Investments, Portfolio & Company Exits
Arkin Bio Ventures has made 22 investments. Their most recent investment was on Feb 13, 2025, when Newleos Therapeutics raised $93.5M. Arkin Bio Ventures has made 7 diversity …See details»
Arkin Bio Ventures investment portfolio | PitchBook
Oct 18, 2023 Arkin Bio Ventures General Information Company Description. Founded in 2016, Arkin Bio Ventures is a venture capital firm based in Tel Aviv, Israel. The firm prefers to invest in early and mid-stage companies that focus …See details»
Arkin Holdings - Crunchbase Investor Profile
Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech, medical device, and digital health technologies. Our synergistic healthcare investments are focused on creating innovations that benefit …See details»
Arkin Bio Ventures - Investor Profile, Portfolio, Investments & Team
Arkin Bio Ventures; Arkin Bio Ventures. https://www.arkinholdings.com Claim Profile. Submit Deck. Become LP. Location: Israel. Investor Type: ... Arkin Holdings is dedicated to …See details»
Arkin Bio Ventures - Golden
Arkin Bio Ventures is a Tel Aviv, Israel based venture capital firm founded in 2016. It is a part of Arkin Holdings. ... Organization. Investor. Venture capital firm. Company. Company attributes.See details»
ADAR MAKOVSKI SILVERSTEIN | Arkin
Adar Makovski Silverstein has been a Principal at Arkin Bio Ventures since 2023. She is part of the ABV3 management team, an early-stage fund focused on Seed and Series A …See details»
Arkin Bio Ventures – Investors Database - Unicorn Nest
The usual cause for the fund is to invest in rounds with 5-6 partakers. The meaningful sponsors for the fund in investment in the same round are Pontifax, M Ventures, MPM Capital. In the …See details»
Arkin Bio Ventures - Crunchbase
Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech and medical device technologies. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Arkin Bioventures Portfolio Investments, Arkin Bioventures Funds, …
Sep 3, 2020 The Series A financing follows an initial seed investment from 4BIO Capital and Arkin Bio Ventures who supported and incubated the company. The round was co-led by …See details»
Arkin Holdings Raises $140 Million in Second Partnership Arkin Bio ...
Mar 9, 2020 “Arkin Bio-Ventures II builds on the success of our earlier, well-established and lucrative fund. Together with our partners, we look forward to further successful investments in …See details»
Arkin Holdings, Phoenix Group unite again on $140M biotech fund
Mar 9, 2020 Arkin Bio-Ventures II comes soon after Andreessen Horowitz raised its third bio fund and Frazier Healthcare Partners netted $617 million for its tenth fund. At $750 million, ...See details»
Israel’s Arkin Holdings raises $140M for second life sciences ...
Mar 10, 2020 The company, based near Tel Aviv, said it plans to invest money from the fund, Arkin Bio-Ventures II, in areas like gene therapy, as well as RNA- and DNA-targeted drugs. By …See details»
PINI ORBACH | Arkin
Dr. Pini Orbach joined Arkin in 2010 and is a Managing Partner overseeing Arkin Bio Ventures and Arkin Bio Capital Funds. Pini has more than 20 years of industry experience as a drug …See details»
Arkin Holdings raises $270 million for new biotech fund
Oct 27, 2021 Arkin Holdings, whose funds have $2 billion in assets under management, has raised $270 million for a new fund it has named Arkin Bio-Capital. In addition to Arkin …See details»
INBAL MICHAILOVICI | Arkin
Inbal Michailovici joined Arkin Bio Ventures as a Principal in 2023. Inbal is part of the ABV3 management team, an early-stage fund focused on seed and Series A breakthrough …See details»